Business Context and Reporting Period
Company: Rogers Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2011
Overview: Rogers Corporation is a global enterprise providing specialty material-based products for markets including portable communications, mass transit, automotive, and clean technology. The quarter was defined by the strategic acquisition of Curamik Electronics GmbH on January 4, 2011, for approximately $151.1 million. This acquisition drove record quarterly sales and necessitated a realignment of the company's reporting segments, creating a new "Power Electronic Solutions" segment.
Key Financial Metrics
| Metric (in thousands) | Q1 2011 | Q1 2010 |
|---|---|---|
| Net Sales | $136,059 | $83,936 |
| Gross Margin | $42,111 | $30,259 |
| Operating Income | $11,591 | $5,742 |
| Net Income | $9,434 | $6,854 |
| Diluted EPS | $0.57 | $0.43 |
| Cash from Operating Activities | $(19,952) | $12,590 |
| Cash from Investing Activities | $(137,686) | $(26,622) |
| Cash from Financing Activities | $141,244 | $380 |
| Long-Term Debt | $145,000 | $0 |
| Cash and Equivalents | $66,135 | $42,761 |
Margins: Gross margin percentage was 31.0% in Q1 2011 compared to 36.1% in Q1 2010. The decline was attributed to raw material cost increases, startup costs for new facilities, and a $1.8 million non-cash inventory write-up related to the Curamik acquisition.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 62.2% year-over-year. Approximately $32.9 million of this growth was attributable to the Curamik acquisition. Organic growth was approximately 23.0%.
- Profitability: Operating income nearly doubled, driven by strong performance in High Performance Foams (up 109.1%) and Power Distribution Systems (moving from break-even to $2.3 million profit).
- Balance Sheet: Long-term debt increased from $0 to $145.0 million due to a draw on a new $165 million credit facility to fund the Curamik acquisition. Goodwill and intangible assets increased by $146.6 million due to the acquisition.
- Cash Flow: Operating cash flow turned negative ($19.9 million outflow) compared to a positive $12.6 million in the prior year, primarily due to increases in accounts receivable and inventory to support higher sales volumes and the acquisition.
Guidance, Outlook, and Risks
Management Commentary: Management expressed cautious optimism, citing a strong product portfolio enhanced by the Curamik acquisition. They anticipate sales from new manufacturing facilities in China (Printed Circuit Materials) and Arizona (Power Distribution Systems) to begin in the second half of 2011. R&D spending targets are being adjusted to a 4-5% range in the short term, with a long-term target of 6%.
Risks and Contingencies:
- Asbestos Litigation: Approximately 214 claims were pending as of March 31, 2011. The company maintains a reserve of $29.7 million for liabilities and $29.3 million for insurance recoveries. Management believes insurance coverage is substantial but notes inherent uncertainties in future projections.
- Environmental Matters: Ongoing remediation for PCB contamination at the Woodstock, Connecticut facility, with projected costs between $0.8 million and $2.4 million.
- Market Risks: Exposure to foreign currency exchange rates (hedged via derivatives), raw material price volatility (specifically copper and PTFE), and potential supply chain disruptions from the natural disaster in Japan.
- Auction Rate Securities: The company holds approximately $37.3 million in par value of auction rate securities, classified as long-term assets with a total impairment of $3.7 million. These are considered other-than-temporarily impaired but the company intends to hold them to recovery.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of synergies and the ability of the Curamik segment to maintain its record sales performance beyond the first quarter.
- Debt Covenants: Confirm continued compliance with the new credit facility covenants, specifically the fixed charge coverage ratio (minimum 3.0:1.0) and leverage ratio (maximum 2.50:1.0).
- Margin Recovery: Monitor whether gross margins can recover from the 31.0% level as raw material costs stabilize and new facility startup costs are absorbed.
- Asbestos Reserves: Review future filings for updates on the 214 pending asbestos claims and the solvency of insurance carriers covering these liabilities.
- Liquidity: Assess the impact of the negative operating cash flow on the company's ability to fund future capital expenditures and R&D without further debt draws.